Cargando…

Extent of neck dissection for patients with clinical N1 oral cancer

BACKGROUND: No clear consensus has been reached on the indication of supraomohyoid neck dissection (SOHND) for clinically positive lymph-node metastasis. PATIENTS: Consecutive 100 patients with previously untreated oral cancer treated at Kobe University Hospital were included in this study. All pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakei, Yasumasa, Komatsu, Hirokazu, Minamikawa, Tsutomu, Hasegawa, Takumi, Teshima, Masanori, Shinomiya, Hirotaka, Otsuki, Naoki, Nibu, Ken-ichi, Akashi, Masaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261274/
https://www.ncbi.nlm.nih.gov/pubmed/32140953
http://dx.doi.org/10.1007/s10147-020-01635-8
_version_ 1783540473838698496
author Kakei, Yasumasa
Komatsu, Hirokazu
Minamikawa, Tsutomu
Hasegawa, Takumi
Teshima, Masanori
Shinomiya, Hirotaka
Otsuki, Naoki
Nibu, Ken-ichi
Akashi, Masaya
author_facet Kakei, Yasumasa
Komatsu, Hirokazu
Minamikawa, Tsutomu
Hasegawa, Takumi
Teshima, Masanori
Shinomiya, Hirotaka
Otsuki, Naoki
Nibu, Ken-ichi
Akashi, Masaya
author_sort Kakei, Yasumasa
collection PubMed
description BACKGROUND: No clear consensus has been reached on the indication of supraomohyoid neck dissection (SOHND) for clinically positive lymph-node metastasis. PATIENTS: Consecutive 100 patients with previously untreated oral cancer treated at Kobe University Hospital were included in this study. All patients were clinically staged as anyTN1M0 and underwent radical dissection of the primary site and level I–V neck dissection as the initial treatment. RESULTS: None of the 100 patients had pathological lymph-node metastasis (pLN) to level V. pLN to level IV was observed in two patients with tongue cancer in whom clinical lymph-node metastasis was preoperatively observed at level II. CONCLUSIONS: Level V may be excluded in the neck dissection for patients with N1 oral cancers. Level IV dissection should be considered in the patient with tongue cancer and clinical lymph-node metastasis at level II.
format Online
Article
Text
id pubmed-7261274
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-72612742020-06-10 Extent of neck dissection for patients with clinical N1 oral cancer Kakei, Yasumasa Komatsu, Hirokazu Minamikawa, Tsutomu Hasegawa, Takumi Teshima, Masanori Shinomiya, Hirotaka Otsuki, Naoki Nibu, Ken-ichi Akashi, Masaya Int J Clin Oncol Original Article BACKGROUND: No clear consensus has been reached on the indication of supraomohyoid neck dissection (SOHND) for clinically positive lymph-node metastasis. PATIENTS: Consecutive 100 patients with previously untreated oral cancer treated at Kobe University Hospital were included in this study. All patients were clinically staged as anyTN1M0 and underwent radical dissection of the primary site and level I–V neck dissection as the initial treatment. RESULTS: None of the 100 patients had pathological lymph-node metastasis (pLN) to level V. pLN to level IV was observed in two patients with tongue cancer in whom clinical lymph-node metastasis was preoperatively observed at level II. CONCLUSIONS: Level V may be excluded in the neck dissection for patients with N1 oral cancers. Level IV dissection should be considered in the patient with tongue cancer and clinical lymph-node metastasis at level II. Springer Singapore 2020-03-05 2020 /pmc/articles/PMC7261274/ /pubmed/32140953 http://dx.doi.org/10.1007/s10147-020-01635-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Kakei, Yasumasa
Komatsu, Hirokazu
Minamikawa, Tsutomu
Hasegawa, Takumi
Teshima, Masanori
Shinomiya, Hirotaka
Otsuki, Naoki
Nibu, Ken-ichi
Akashi, Masaya
Extent of neck dissection for patients with clinical N1 oral cancer
title Extent of neck dissection for patients with clinical N1 oral cancer
title_full Extent of neck dissection for patients with clinical N1 oral cancer
title_fullStr Extent of neck dissection for patients with clinical N1 oral cancer
title_full_unstemmed Extent of neck dissection for patients with clinical N1 oral cancer
title_short Extent of neck dissection for patients with clinical N1 oral cancer
title_sort extent of neck dissection for patients with clinical n1 oral cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261274/
https://www.ncbi.nlm.nih.gov/pubmed/32140953
http://dx.doi.org/10.1007/s10147-020-01635-8
work_keys_str_mv AT kakeiyasumasa extentofneckdissectionforpatientswithclinicaln1oralcancer
AT komatsuhirokazu extentofneckdissectionforpatientswithclinicaln1oralcancer
AT minamikawatsutomu extentofneckdissectionforpatientswithclinicaln1oralcancer
AT hasegawatakumi extentofneckdissectionforpatientswithclinicaln1oralcancer
AT teshimamasanori extentofneckdissectionforpatientswithclinicaln1oralcancer
AT shinomiyahirotaka extentofneckdissectionforpatientswithclinicaln1oralcancer
AT otsukinaoki extentofneckdissectionforpatientswithclinicaln1oralcancer
AT nibukenichi extentofneckdissectionforpatientswithclinicaln1oralcancer
AT akashimasaya extentofneckdissectionforpatientswithclinicaln1oralcancer